Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib in Severe Alopecia Areata
NCT07645430Completed
- Sponsor
- Benha University
- Start
- Jan 2023
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial of baricitinib in alopecia areata, sponsored by Benha University. Primary endpoints: Serum level of Interleukin-15 at 6 months and Serum level of Interferon Gamma at 6 months. Started Jan 2023; status: completed.
02
Drugs
baricitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT07645430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07645430.